MedTrace Logo

Early Prediction of Fluoxetine Response

NCT01075529 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2010-02-25

No results posted yet for this study

Summary

The purpose of this study is to identify what degree of symptom changes during the early weeks could be used to predict eventual nonresponse at week 6 among depressive inpatients taking fluoxetine.

Conditions

Interventions

DRUG

fluoxetine

fluoxetine 20 mg/d

Sponsors & Collaborators

  • Kaohsiung Kai-Suan Psychiatric Hospital

    lead OTHER_GOV

Principal Investigators

  • Ching-Hua Lin, M.D. · Kai-Suan Psychiatric Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01075529 on ClinicalTrials.gov